← SynDRA
PSB-06126
SynDRA canonical compound SYN0086759 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | ENTPD3 |
| Mechanism of action | NTPDase inhibitor |
All known targets
Mechanisms of action (all sources)
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- CDK2
- P2RY12
- P2RY2
- P2RY4
- APEX1
- BLM
- KAT2A
- POLK
- RECQL
- TDP1
- THRB
- VDR
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- SCHEMBL13214120
- SCHEMBL29354313
- CHEBI:93255
- PD070443
- 1-amino-2-sulfo-4-(1-naphthylamino)anthraquinone
- BRD-K71266197-236-01-9
- BRD-K71266197-236-02-7
- 1-amino-4-(1-naphthalenylamino)-9,10-dioxo-2-anthracenesulfonic acid
- SCHEMBL29502819
- DA-57183
- HMS3677H13
- EX-A7090
- NCGC00167780-01
- MFCD09971095
- orb1704198
- HMS3269D03
- T23193
- G78938
- PSB-06126?
- SCHEMBL792522
- C24H15N2NaO5S
- HMS3413H13
- MS-32627
- HY-103263
- AKOS024457176
- CS-0026732
Look up PSB-06126 in the interactive SynDRA portal →